Search research articles
Contact Us
Filters
Showing results (21-30 of 286) with videos related to
Page
of 29
Sort By:
The Lancet. Oncology
|
January 14, 2016
Melatonin: resetting the clock of cancer progression?
David J Pinato, Justin Stebbing
Gastroenterology
|
January 30, 2023
Tumor-infiltrating Neutrophils: Gatekeepers in Liver Cancer Immune Control
Bernhard Scheiner, David J Pinato
Cancer Discovery
|
July 1, 2024
Precision Targeting of the Gut Microbiome for Cancer Immunotherapy
Pasquale Lombardi, David J Pinato
Gastroenterology
|
December 8, 2023
Fecal Microbiota Transplantation to Reverse Host-Related Determinants of Resistance to Anticancer Immunotherapy
Paolo Davide D'arienzo, David J Pinato
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
October 19, 2017
Regression of Paraneoplastic Rash after Lung Cancer Chemotherapy
David J Pinato, Thomas Newsom-Davis
Gastroenterology
|
June 17, 2023
Measuring the Invisible: Circulating Tumor DNA as a Predictive and Prognostic Marker of Response to Adjuvant Chemotherapy in Resected Colorectal Cancer
Paolo D D'Arienzo, David J Pinato
Gastroenterology
|
September 30, 2023
Inflammation as a Pathogenic Mechanism of Colonic Neoplasia in Primary Sclerosing Cholangitis
Giulia F Manfredi, David J Pinato
The Lancet. Gastroenterology & Hepatology
|
June 16, 2023
Immune checkpoint inhibitors in hepatocellular carcinoma: emerging challenges in clinical practice
Matthias Pinter, Bernhard Scheiner, David J Pinato
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 2, 2023
Diabetes and Immune Checkpoint Inhibitors-Response
Alessio Cortellini, Antonio D'Alessio, David J Pinato
Journal of Hepatology
|
November 29, 2016
Reply to: 'Validating the ALBI grade: Its current and future use in HCC prognostication'
David J Pinato, Clarence Yen, Rohini Sharma
Page
of 29
Search research articles
Search
Showing results (21-30 of 286) with videos related to
Sort By:
Page
of 29
The Lancet. Oncology
|
January 14, 2016
Melatonin: resetting the clock of cancer progression?
David J Pinato, Justin Stebbing
Gastroenterology
|
January 30, 2023
Tumor-infiltrating Neutrophils: Gatekeepers in Liver Cancer Immune Control
Bernhard Scheiner, David J Pinato
Cancer Discovery
|
July 1, 2024
Precision Targeting of the Gut Microbiome for Cancer Immunotherapy
Pasquale Lombardi, David J Pinato
Gastroenterology
|
December 8, 2023
Fecal Microbiota Transplantation to Reverse Host-Related Determinants of Resistance to Anticancer Immunotherapy
Paolo Davide D'arienzo, David J Pinato
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
October 19, 2017
Regression of Paraneoplastic Rash after Lung Cancer Chemotherapy
David J Pinato, Thomas Newsom-Davis
Gastroenterology
|
June 17, 2023
Measuring the Invisible: Circulating Tumor DNA as a Predictive and Prognostic Marker of Response to Adjuvant Chemotherapy in Resected Colorectal Cancer
Paolo D D'Arienzo, David J Pinato
Gastroenterology
|
September 30, 2023
Inflammation as a Pathogenic Mechanism of Colonic Neoplasia in Primary Sclerosing Cholangitis
Giulia F Manfredi, David J Pinato
The Lancet. Gastroenterology & Hepatology
|
June 16, 2023
Immune checkpoint inhibitors in hepatocellular carcinoma: emerging challenges in clinical practice
Matthias Pinter, Bernhard Scheiner, David J Pinato
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 2, 2023
Diabetes and Immune Checkpoint Inhibitors-Response
Alessio Cortellini, Antonio D'Alessio, David J Pinato
Journal of Hepatology
|
November 29, 2016
Reply to: 'Validating the ALBI grade: Its current and future use in HCC prognostication'
David J Pinato, Clarence Yen, Rohini Sharma
Page
of 29